ALEXANDRIA, Va., April 21 -- United States Patent no. 12,605,473, issued on April 21, was assigned to REGENERON PHARMACEUTICALS INC. (Tarrytown, N.Y.).
"Methods for making radiolabeled anti-MET binding proteins" was invented by Marcus Kelly (New York), Dangshe Ma (Millwood, N.Y.) and William Olson (Yorktown Heights, N.Y.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Radiolabeled anti-MET antibodies and METxMET bispecific antibodies and their use in immuno-PET imaging are provided herein. Included are methods of detecting the presence of MET proteins in a subject or sample and methods of monitoring efficacy of treatment of a Met expressing tumor."
The patent was filed on Dec. 29, 2023, under Application No....